FDA Approves Pancreatic Enzyme Products to Aid Digestion

02 Mar 2012 --- Ultresa is a delayed-release capsule used to treat children and adults with cystic fibrosis, a serious genetic disorder affecting the lungs and other organs, or other conditions who cannot digest food normally because their pancreas does not make enough pancreatic enzymes.

Mar 2 2012 --- Two new pancreatic enzyme products used to help aid food digestion, Ultresa (pancrelipase) and Viokace (pancrelipase), were approved by the U.S. Food and Drug Administration.

Ultresa is a delayed-release capsule used to treat children and adults with cystic fibrosis, a serious genetic disorder affecting the lungs and other organs, or other conditions who cannot digest food normally because their pancreas does not make enough pancreatic enzymes.

Viokace, in combination with a proton pump inhibitor, is used to treat adults who cannot digest food normally. Adults with chronic pancreatitis, a continuing, chronic inflammatory process of the pancreas, or those who have had some or all of their pancreases removed (pancreatectomy) may not digest food normally because they lack needed enzymes or because their enzymes are not released into the bowel (intestine). Viokace’s safety and efficacy in children has not been established.

“The approvals of Ultresa and Viokace, along with the other approved pancreatic enzyme products, allow health care providers to prescribe the product that is most appropriate for the estimated 200,000 patients in the United States who have pancreatic insufficiency,” said Julie Beitz, M.D., director of the Office of Drug Evaluation III in FDA’s Center for Drug Evaluation and Research.

Ultresa and Viokace are the fourth and fifth pancreatic enzyme products approved by FDA. Other FDA-approved pancreatic enzyme products include Creon (2009), Zenpep (2009) and Pancreaze (2010). Approved pancreatic enzyme products meet FDA standards for safety, efficacy and product quality.

Unapproved pancreatic enzyme products had been available for many years. FDA established a date of April 28, 2010 for the makers of pancreatic enzyme products to stop manufacturing and distributing unapproved products.

Ultresa and Viokace are marketed by Bridgewater, N.J.-based Aptalis Pharma U.S. Inc.
 

Related Articles

Business News

Soy Protein Can Improve Diet Quality and Appetite Control in Teens

22 May 2015 --- A new study published in the latest edition of The Journal of Nutrition found that consumption of a protein-rich afternoon snack containing soy protein resulted in reductions in appetite, a greater delay in subsequent eating, and improved diet quality in teens compared to other snack options. The study, titled, “Protein Snacks Improve Appetite and Diet Quality in Teens,” is the first study of its kind to examine whether replacement of a high fat / high sugar snack with a healthier version would lead to improvements in obesity-related outcomes in overweight young people.

Health & Nutrition News

UK Researchers Map Gut Change Across the Life Course

22 May 2015 --- Scientists and clinicians on the Norwich Research Park have carried out the first detailed study of how our intestinal tract changes as we age, and how this determines our overall health.

Health & Nutrition News

Tesco Commits to Major Sugar Reduction Programme for Own-Label Soft Drinks

21 May 2015 --- Tesco has become the first major British retailer to commit to a major sugar reduction programme with a 5% year-on-year, open-ended reduction in sugar across its entire sugary soft drinks range. The news has triggered campaign group Action on Sugar to call on the UK’s Health Secretary Jeremy Hunt MP to implement this strategy across the whole food and drink industry. 

Health & Nutrition News

Probiotics May Shorten Duration of Common Cold

21 May 2015 --- With the completion and publication of the world’s largest clinical study on the immune effect of probiotics in adults, Chr. Hansen has obtained results indicating that the probiotic strain named L. CASEI 431 can shorten the duration of common cold and influenza-like illness, lower the use of health care resources and reduce use of antibiotics.

More Articles
URL : http://www.nutritioninsight.com:80/news/FDA-Approves-Pancreatic-Enzyme-Products-to-Aid-Digestion.html